Apr 11

TOBI Faculty Publications: March 2018

Below is a resource of all March 2018 regenerative medicine publications authored by TOBI Speakers and Faculty, including alumni faculty. Each month, we compile a list with links and brief summaries of all new research and studies to keep TOBI community members informed and on the cutting edge of regenerative medicine research. Studies are listed alphabetically by TOBI Faculty names. If you are a TOBI Faculty member or alumni and would like your publications included in the TOBI monthly publications...

Nov 7

TOBI Faculty Publications: October 2017

1 Oct 2017 The American Journal of Sports Medicine Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection: A 1-Year Pilot Double-Blinded Randomized Controlled Trial The purpose of this study, by TOBI Faculty Alumni Peter Verdonk, MD, is to investigate if one intra-articular injection of autologous protein solution (APS) can reduce pain and improve function in patients affected by knee OA in a multicenter, randomized, double-blind, saline-controlled study. This study provides evidence to support the safety and...

Nov 6

TOBI Faculty Andrew Ittleman on the FDA’s Regulation of Stem Cells

TOBI 2017 Faculty Andrew Ittleman, JD, has published a valuable article on how the FDA should regulate human cells. This article, which appeared in The Regulatory Review, provides a brief history of the FDA's involvement in the regulation of human cells, starting with the Wall Street Journal Op-ed, "The FDA Wants to Regulate Your Cells", written by Scott Gottlieb in 2012. Gottlieb is now the Commissioner of the FDA. Ittleman analyzes Gottlieb's political history regarding the regulation of human cells,...